Quotes 5-day view Delayed Nyse
01/08/2021
01/11/2021
01/12/2021
01/13/2021
01/14/2021
Date
23.27(c)
22.59(c)
23.12(c)
23.06(c)
23.91(c)
Last
1 388 155
760 712
565 672
1 434 163
733 253
Volume
-1.19% -2.92% +2.35% -0.26% +3.69% Change
Sales 2020
2 078 M - -
Net income 2020
-7,25 M - -
Net Debt 2020
1 161 M - -
P/E ratio 2020
-2,77x
Yield 2020
-
Sales 2021
1 855 M - -
Net income 2021
99,4 M - -
Net Debt 2021
921 M - -
P/E ratio 2021
20,2x
Yield 2021
-
Capitalization
2 005 M 2 005 M -
EV / Sales 2020
1,52x
EV / Sales 2021
1,58x
Nbr of Employees
9 480
Free-Float
96,7%
MEDNAX, Inc is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company's national network consist of physicians, including over physicians providing neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It also has affiliated...
Notations Surperformance© of MEDNAX, Inc.
Trading Rating : Investor Rating :
All news about MEDNAX, INC.
News in other languages on MEDNAX, INC.
Analyst Recommendations on MEDNAX, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends MEDNAX, INC.
Short Term Mid-Term Long Term Trends Neutral Bullish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
11
Average target price
20,80 $
Last Close Price
23,91 $
Spread / Highest target
8,74%
Spread / Average Target
-13,0%
Spread / Lowest Target
-41,4%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
